Autoinducers enable bacteria to sense cell density and to coordinate collective behavior. NTD/kanosamine is an autoinducer produced by B. subtilis and several close relatives, although its physiological function remains unknown.
KEYWORDS: Bacillus subtilis, autoinducer, kanosamine, metabolome, neotrehalosadiamine
ABSTRACT
The pentose phosphate (PP) pathway is one of the major sources of cellular NADPH. A Bacillus subtilis zwf mutant that lacks glucose-6-phosphate dehydrogenase (the enzyme that catalyzes the first step of the PP pathway) showed inoculum-dose-dependent growth. This growth defect was suppressed by glcP disruption, which causes the upregulation of the autoinducer neotrehalosadiamine (NTD)/kanosamine biosynthetic pathway. A metabolome analysis showed that the stimulation of NTD/kanosamine biosynthesis caused significant accumulation of tricarboxylic acid (TCA) cycle intermediates and NADPH. Because the major malic enzyme YtsJ concomitantly generates NADPH through malate-to-pyruvate conversion, de novo NTD/kanosamine biosynthesis can result in an increase in the intracellular NADPH pool via the accumulation of malate. In fact, a zwf mutant grew in malate-supplemented medium. Artificial induction of glcP in the zwf mutant caused a reduction in the intracellular NADPH pool. Moreover, the correlation between the expression level of the NTD/kanosamine biosynthesis operon ntdABC and the intracellular NADPH pool was confirmed. Our results suggest that NTD/kanosamine has the potential to modulate carbon energy metabolism through an autoinduction mechanism.
IMPORTANCE Autoinducers enable bacteria to sense cell density and to coordinate collective behavior. NTD/kanosamine is an autoinducer produced by B. subtilis and several close relatives, although its physiological function remains unknown. The most important finding of this study was the significance of de novo NTD/kanosamine biosynthesis in the modulation of the central carbon metabolism in B. subtilis. We showed that NTD/kanosamine biosynthesis caused an increase in the NADPH pool via the accumulation of TCA cycle intermediates. These results suggest a possible role for NTD/kanosamine in carbon energy metabolism. As Bacillus species are widely used for the industrial production of various useful enzymes and compounds, the NTD/kanosamine biosynthetic pathway might be utilized to control metabolic pathways in these industrial strains.
INTRODUCTION
Autoinduction is a gene regulation mechanism that relies on self-produced signaling molecules called autoinducers. By monitoring the accumulation of autoinducers in the surrounding environment, bacteria can sense cell population density and adapt accordingly by altering gene expression (quorum sensing) (1–4). This mechanism is widespread in the bacterial world and is known to control various important processes, including competence, sporulation, motility, biofilm formation, and virulence. In general, Gram-negative bacteria communicate using acyl-homoserine lactones (5), while Gram-positive bacteria use peptides (6). Moreover, a furanosyl borate diester, autoinducer 2 (AI-2), acts as a universal signal for interspecies communication (7).
Neotrehalosadiamine (NTD; 3,3′-diamino-3,3′-dideoxy-α,β-trehalose) is a structurally unique autoinducer consisting of two kanosamine (3-amino-3-deoxy-d-glucose) residues with a 1,1′-α,β linkage (Fig. 1). Several Bacillus species, including Bacillus subtilis, possess the ability to produce NTD, although its physiological role remains unknown (8–10). NTD induces at least the expression of its biosynthetic operon ntdABC by binding to the transcriptional activator NtdR (10). Biochemical analyses performed by another research group showed that the ntdABC operon exclusively contains enzymes to produce the kanosamine moiety from glucose-6-phosphate (G6P) (11, 12). However, the enzyme that catalyzes the last step of NTD biosynthesis (i.e., the formation of the 1,1′-α,β linkage of kanosamine moieties) has not been identified.
FIG 1.

Chemical structures of NTD and kanosamine.
The expression of ntdABC is repressed during the exponential growth phase, even in the presence of excess NTD. This repression is exerted by the function of GlcP, which was annotated as a glucose/mannose:H+ symport permease (13). The gene encoding GlcP, glcP, is located immediately downstream of ntdABC and is cotranscribed with ntdABC via transcriptional readthrough at the ntdABC transcriptional terminator site (14). Our previous transcriptional analysis revealed that ntdABC expression is apparently repressed through GlcP-mediated glucose transport (14). Moreover, disruption of the glcP gene caused derepression of ntdABC, thereby leading to NTD/kanosamine overproduction. Considering that glcP mutant cells can incorporate glucose as well as wild-type cells do (14), it seems that GlcP acts as a glucose sensor for controlling ntdABC expression, rather than for glucose uptake. Although the glucose incorporated through GlcP is unphosphorylated, the glucose incorporated through the predominant glucose uptake pathway, i.e., the glucose-specific phosphoenolpyruvate (PEP)-dependent phosphotransferase system (glucose-PTS), is phosphorylated to G6P during the permeation process (15). As G6P can serve as a substrate for the first step of the NTD/kanosamine biosynthetic pathway, glucose has a positive effect on NTD/kanosamine biosynthesis through the glucose-PTS. Furthermore, NTD production is severely reduced by disruption of ccpA (14), which encodes a master regulator for carbon catabolite regulation (16). This indicates that NTD production is also regulated by the CcpA-dependent catabolite activation mechanism, either directly or indirectly. Thus, glucose has both positive and negative effects on NTD production, depending on the uptake pathway. Therefore, we hypothesized that NTD is an extracellular signal for sensing both glucose availability and cell density.
In this work, we began to investigate the physiological role of NTD in glucose metabolism. The pentose phosphate (PP) pathway is a major source of the reducing power of NADPH and metabolic intermediates for biosynthetic processes. Because both the NTD/kanosamine biosynthetic pathway and PP pathway branch from G6P, we examined the correlation between these two pathways. During the course of this study, we found that upregulation of the NTD/kanosamine biosynthetic pathway can suppress the growth defect of a zwf mutant lacking glucose-6-phosphate dehydrogenase, which is the enzyme that catalyzes the first step of the PP pathway. A metabolome analysis revealed that the activation of the NTD/kanosamine biosynthetic pathway resulted in an increase in the intracellular NADPH level, leading to recovery of the growth of the zwf mutant. The correlation between NTD/kanosamine biosynthesis and the intracellular NADPH level is discussed.
RESULTS
Kanosamine also acts as an autoinducer of the ntdABC operon.
We first examined whether kanosamine also acts as an autoinducer of ntdABC. Using reporter strains carrying an ntdABC promoter (PntdABC)-lacZ fusion at the amyE locus, the effect of kanosamine on PntdABC activity was monitored (Fig. 2A). Addition of excess kanosamine to the growth medium apparently activated PntdABC in an NTD/kanosamine nonproducer strain, TI482 (ntdA::Tn10), indicating that extracellular kanosamine can act as an autoinducer of PntdABC. This effect was not observed in the ntdR mutant, indicating that kanosamine-driven autoinduction is mediated by NtdR in addition to NTD. As shown in Fig. 2B, the responsiveness of the promoter to kanosamine was comparable to that observed for NTD (Fig. 2B). Thus, B. subtilis can respond to both NTD and kanosamine at extracellular concentrations of 0.3 μM or higher. In the wild-type strain, the amount of NTD/kanosamine produced under our culture condition was estimated to be approximately 5 to 10 μM, as predicted from the activity of PntdABC (Fig. 2).
FIG 2.

Autoinduction effect of kanosamine on the ntdABC promoter in B. subtilis. (A) The B. subtilis reporter strains TI352 (wild type), TI481 (ntdR), and TI482 (ntdA) were inoculated into S7N medium without (white bars) or with (gray bars) kanosamine. Kanosamine was added to the growth medium at a concentration of 200 μg/ml (0.93 mM). Culture samples were collected at 16 h, and β-galactosidase activities were measured. The asterisks denote significant differences compared with the values obtained in the absence of kanosamine (P < 0.05). (B) The B. subtilis reporter strain TI482 (ntdA) was inoculated into S7N medium containing kanosamine (open circles) or NTD (closed circles) at the indicated concentration. Culture samples were collected at 16 h, and β-galactosidase activities were measured. The line indicates the basal activity of the ntdABC promoter in cells grown in nonsupplemented medium. The average values from three independent experiments are shown. The error bars represent the standard deviations.
Activation of the NTD/kanosamine biosynthetic pathway can suppress the growth defect caused by zwf disruption.
The NTD/kanosamine biosynthetic pathway and the PP pathway both branch from G6P. In the first step of the PP pathway, G6P dehydrogenase, which is encoded by the zwf gene, converts G6P to 6-phospho-gluconolactone. To examine whether NTD/kanosamine production is affected by the knockout of the zwf gene, several zwf disruption mutants [i.e., TI443 (zwf), TI444 (zwf glcP), and TI445 (zwf ntdABC glcP)] were constructed. The zwf mutant grew as well as the wild-type 168 strain in liquid LB medium with 1% (vol/vol) of the inoculum. However, when the LB overnight culture was inoculated into semisynthetic S7N medium containing excess glucose and glutamate, this mutant showed an inoculation-volume-dependent growth. Although the zwf mutant grew with 2% (vol/vol) of the inoculum (Fig. 3A), a lower-dose inoculum (1 or 0.5%) caused growth arrest or cell lysis (Fig. 3B and C). Inoculation-volume-dependent growth was also observed in an experiment using water-washed cells (data not shown). Supplementation with LB (2%), casamino acid (0.1%), purines (0.2 mM each adenosine and guanosine), or pyrimidines (0.2 mM each thymidine and cytidine) had no significant effect on the growth of the zwf mutant (data not shown). Hence, this growth phenomenon was unlikely to be caused by any carryover effect. Interestingly, the NTD/kanosamine-overproducing zwf glcP double mutant grew with 1% (vol/vol) of the inoculum (Fig. 3D) but not 0.5% (data not shown). Further disruption of the NTD/kanosamine biosynthesis operon ntdABC completely negated the effect of glcP disruption on cell growth (Fig. 3D). No significant restoration of the growth of the zwf mutant was observed in S7N medium supplemented with NTD or kanosamine at the concentration of 1 mM, because NTD/kanosamine-driven autoinduction was prevented during the exponential growth phase, even in the presence of excess NTD/kanosamine (data not shown). These results suggest that the activation of the de novo NTD/kanosamine biosynthetic pathway can cause alterations in metabolism, thereby suppressing the growth defect of the zwf mutant.
FIG 3.

Growth characteristics of B. subtilis zwf mutants. The B. subtilis 168 (wild type) (open circles) and TI443 (zwf) (closed circles) strains were grown in LB medium for 16 h at 37°C. An appropriate volume of the overnight culture was inoculated into S7N medium, and growth was monitored by measuring the OD650. The inoculum was 2% (vol/vol) (A), 1% (vol/vol) (B), or 0.5% (vol/vol) (C). (D) The growth of the B. subtilis 168, TI443, NTD/kanosamine overproducer TI444 (zwf glcP), and NTD/kanosamine nonproducer TI445 (zwf ntdABC glcP) strains with the 1% inoculum is shown. The average values from three independent experiments are shown. The error bars represent the standard deviations.
The effect of upregulation of the NTD/kanosamine biosynthetic pathway on metabolism.
To clarify the metabolic changes, we performed a metabolome analysis (Fig. 4). The disruption of zwf caused a remarkable decrease in the intracellular levels of PP pathway intermediates, resulting in decreased levels of NADPH and phosphoribosyl pyrophosphate (PRPP) (Fig. 4). The signal corresponding to kanosamine was observed only in the zwf glcP double mutant, indicating that the NTD/kanosamine biosynthetic pathway was actually activated only in the zwf glcP mutant. Although no significant increases in the intracellular levels of PP pathway intermediates were observed even in the zwf glcP mutant, the intracellular NADPH level in this mutant was increased as much as that observed in the wild-type strain. Conversely, no significant increase in the intracellular NADPH level was observed in the zwf ntdABC glcP triple mutant. A similar result was obtained in an NADPH assay that was performed using the crude extract of each strain (see Fig. S1 in the supplemental material), which suggests that upregulation of the NTD/kanosamine biosynthetic pathway can stimulate NADPH production without a contribution from the oxidative PP pathway. The metabolome profile revealed that the activation of the NTD/kanosamine biosynthetic pathway had a significant effect on glycolysis/gluconeogenesis and the tricarboxylic acid (TCA) cycle, rather than on the PP pathway. The intermediates of these metabolic pathways accumulated only in the zwf glcP mutant (Fig. 4). As the conversion of isocitrate to 2-oxoglutarate (2OG) by isocitrate dehydrogenase (IDH) in the TCA cycle is one of the major sources of NADPH generation, we assessed the effect of NTD/kanosamine on IDH activity. However, glcP disruption had no significant effect on IDH activity (data not shown). Therefore, we considered that the NTD/kanosamine biosynthesis stimulated another route for NADPH generation. In the second step of the NTD/kanosamine biosynthetic pathway, NtdA catalyzes the conversion of 3-oxoglucose 6-phosphate to kanosamine 6-phosphate through a pyridoxal phosphate (PLP)-dependent amination reaction (12). Because PLP reacts with a glutamate to form pyridoxamine phosphate (PMP) and 2OG (11), the activation of the NTD/kanosamine biosynthetic pathway can cause the accumulation of 2OG. In turn, the accumulated 2OG can enter the TCA cycle, thus increasing the other TCA cycle intermediates, including malate (Fig. 4). B. subtilis possesses four malic enzymes (MaeA, MalS, MleA, and YtsJ), which catalyze the decarboxylation of malate to pyruvate with concomitant reduction of NAD+ or NADP+. YtsJ, which is the major malic enzyme, utilizes NADP+, whereas the remaining enzymes utilize NAD+ (17). Thus, the accumulation of malate can lead to an increase in the intracellular NADPH level through malate-to-pyruvate conversion by YtsJ. Accordingly, we confirmed the effect of several TCA cycle intermediates (malate, succinate, and fumarate) on the growth of the zwf mutant. Strikingly, the addition of malate to S7N medium restored the growth of the zwf mutant, although the maximum cell mass reached only half of that of the wild-type strain (Fig. 5A). Moreover, the intracellular NADPH level in cells that were grown in malate-supplemented medium was increased as much as 2-fold compared with that detected in cells grown in nonsupplemented medium (Fig. 5B). Neither succinate nor fumarate had a recovery effect on the growth of the zwf mutant (data not shown). In B. subtilis, malate is a preferred carbon source that is coutilized with glucose (18). It has been reported that the expression of maeN, which encodes the malate-specific uptake transporter, is induced by malate (19). In contrast, the expression of the C4-dicarboxylic transporter for succinate and fumarate, which is encoded by dctP, is subjected to catabolite repression in the presence of glucose or malate (20, 21). Therefore, it is not surprising that malate alone restored the growth of the zwf mutant. We sought to construct a zwf ytsJ double mutant. However, this attempt was unsuccessful, suggesting that simultaneous disruption of zwf and ytsJ causes synthetic lethality (data not shown).
FIG 4.
Effect of upregulation of NTD/kanosamine biosynthetic pathway on central carbon metabolism. The B. subtilis 168 (wild type), TI443 (zwf), TI444 (zwf glcP), and TI445 (zwf ntdABC glcP) strains were grown in LB medium for 16 h at 37°C. One milliliter of the overnight culture was inoculated in 50 ml of S7N medium and cultivated until the OD650 reached 0.2, and the cells were collected by filtration. The metabolites in each cell were analyzed using CE-TOF MS. The y axis indicates the amount of metabolites (picomoles per OD650 unit per milliliter of culture). 3PG/2PG and kanosamine/mannosamine/glucosamine were not differentiated by the CE-TOF MS method used. The average values from three independent experiments are shown. The error bars represent the standard deviations. Abbreviations: 1,3-BPG, 1,3-bis-phosphoglycerate; 2-OG, 2-oxoglutarate; 2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; 6PG, 6-phosphogluconate; AcCoA, acetyl coenzyme A; DHAP, dihydroxyacetone phosphate; E4P, erythrose 4-phosphate; F1,6P, fructose 1,6-bis-phosphate; F6P, fructose 6-phosphate; G3P, glyceraldehyde 3-phosphate; Glu, glutamate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PLP, pyridoxal phosphate; PMP, pyridoxamine phosphate; PRPP, phosphoribosyl pyrophosphate; R5P, ribose 5-phosphate; Ru5P, ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; SucCoA, succinyl coenzyme A; X5P, xylulose 5-phosphate.
FIG 5.

Effect of malate in the B. subtilis zwf mutant. (A) The B. subtilis 168 (wild type) and TI443 (zwf) strains were grown in LB medium for 16 h at 37°C. The overnight culture was inoculated at 1:100 into S7N medium without or with 0.2% malate. Growth was monitored by measuring the OD650. (B) At an OD650 of 0.2 to 0.3, cells were collected by centrifugation and used for the NADPH assay. The average values from three independent experiments are shown. The error bars represent the standard deviations. The asterisks denote significant differences compared with the value obtained in the absence of malate (P < 0.05).
Correlation between ntdABC expression and the intracellular NADPH level.
The expression of ntdABC is repressed through GlcP-mediated glucose transport (14). To confirm the correlation between ntdABC expression and the intracellular NADPH level, we constructed two engineered strains in which the expression of glcP is controlled by the isopropyl-β-d-thiogalactopyranoside (IPTG)-dependent spac promoter (Pspac) (Fig. 6A). For this purpose, the pMutinT3 plasmid was integrated immediately downstream (TI451) or upstream (TI480) of the ntdABC terminator (TntdABC). The TI451 (zwf ntdABC-TntdABC-pMutinT3-glcP) strain showed growth arrest even in the absence of IPTG (without artificial induction of glcP) because of the leaky expression of glcP from Pspac (see Fig. S2 in the supplemental material). This suggests that a very low level of glcP expression was sufficient to repress the expression of ntdABC. In contrast, the TI480 (zwf ntdABC-pMutinT3-TntdABC-glcP) strain grew normally in the absence of IPTG (Fig. 6B). The growth of the TI480 strain was inhibited in a dose-dependent manner by the addition of IPTG to the growth medium (Fig. 6B). The addition of IPTG at a concentration of 30 μM caused growth arrest. A transcriptional analysis revealed that an induction of ntdA of at least 50-fold compared with that in the wild-type strain 168 was required for the growth of the zwf mutant (Fig. 6C). Furthermore, the intracellular level of NADPH was apparently reduced in an IPTG-dependent manner (Fig. 6D). Thus, the increased expression of ntdA resulted in an increase in the intracellular NADPH pool, thus restoring the growth of the zwf mutant. Our results suggest that NTD/kanosamine functions as a metabolic modulator through autoinduction.
FIG 6.
Effect of glcP expression on the intracellular NADPH pool. (A) For artificial control of glcP expression, the B. subtilis strain TI480 was constructed by integrating the pMutinT3 plasmid immediately upstream of TntdABC. In this strain, glcP is transcribed from the IPTG-dependent Pspac promoter via transcriptional readthrough at TntdABC. (B) Overnight culture was inoculated at 1:100 into S7N medium containing IPTG at the indicated concentrations. The growth was monitored by measuring the OD650. When the culture OD650 reached 0.2 to 0.3, cells were collected by centrifugation and used for RT-qPCR analysis (C) or NADPH assay (D). The relative expression of ntdA is expressed as the ratio compared with that detected in wild-type strain 168. The average values from at least four independent experiments are shown. The error bars represent the standard deviations. The asterisks denote significant differences compared with the value obtained in the absence of IPTG (P < 0.05).
DISCUSSION
This study found a significant correlation between NTD/kanosamine biosynthesis and the intracellular NADPH pool. Our results suggest a possible role for NTD/kanosamine in the metabolism of B. subtilis and probably other NTD/kanosamine-producing close relatives.
The major routes for NADPH generation are considered to be the oxidative PP pathway and IDH in the TCA cycle. Under our culture condition, the intracellular NADPH level in a zwf mutant was only approximately 20% of that detected in the wild-type strain, indicating that NADPH generation largely depends on the oxidative PP pathway (Fig. 4; see also Fig. S1 in the supplemental material). We found that the zwf mutant exhibited inoculum-dose-dependent growth in S7N medium (Fig. 3A to C). Even in LB medium, with a much-lower-dose inoculum (below 0.01%), this mutant showed an extremely extended growth lag (unpublished result). These observations suggest that the PP pathway plays a more critical role in growth with a lower-dose inoculum than in growth with a higher-dose inoculum. The PP pathway is also important for supplying precursors of nucleotide synthesis. Although a marked reduction of PRPP was observed in the zwf mutant (Fig. 4), no significant reduction in nucleotide pools, with the exception of IMP, was observed (data not shown). Moreover, the addition of purine or pyrimidine nucleosides to the S7N medium did not restore the growth of the zwf mutant (data not shown). Therefore, we considered that the major cause of the growth defect observed in this mutant was the limited availability of the intracellular NADPH pool. In support of this hypothesis, a significant correlation between the NADPH level and growth was observed (Fig. 6B and D). Cell growth starting from a lower cell density might require much more NADPH for anabolism. We have already isolated several zwf suppressor mutants that can grow with a lower-dose inoculum (unpublished results). Further analysis of these suppressor mutations will help elucidate the role of the PP pathway in growth with a lower-dose inoculum.
The intracellular NADPH pool was recovered in the zwf glcP double mutant but not in the zwf ntdABC glcP triple mutant, indicating that activation of NTD/kanosamine biosynthetic pathway can stimulate NADPH production without the contribution of the PP pathway (Fig. 4; Fig. S1). IDH in the TCA cycle is an alternative route for NADPH generation. In exponentially growing cells, the genes that encode the first three TCA cycle enzymes (i.e., citrate synthase, aconitase, and IDH) are synergistically repressed by a readily metabolized carbon-nitrogen source, such as glucose and glutamate/glutamine (22, 23). Moreover, the disruption of glcP had no significant effect on IDH activity (data not shown). It appears that IDH had a limited contribution to NADPH generation in the zwf glcP mutant, suggesting the stimulation of another route for NADPH generation. One possible route is the malic enzyme YtsJ, which catalyzes the decarboxylation of malate with concomitant generation of NADPH. The activity of the NADP-dependent malic enzyme in zwf mutant was approximately 2-fold higher than that in the wild-type strain (see Fig. S3 in the supplemental material). However, neither the glcP disruption nor kanosamine per se had any detectable effect on the activity. Because the first steps of the TCA cycle are repressed under nutrient-rich conditions, it is possible that YtsJ-mediated NADPH production is restricted at the intracellular malate level. Considering that upregulation of the NTD/kanosamine biosynthetic pathway caused the accumulation of several TCA cycle intermediates, including malate (Fig. 4), the NTD/kanosamine biosynthetic pathway can contribute to YtsJ-mediated NADPH generation. In fact, addition of malate to S7N medium caused an increase in the intracellular NADPH level (Fig. 5B). It should be noted that the intracellular NADPH level in the zwf mutant growing in malate-supplemented medium reached only approximately half of that detected in the wild-type strain (Fig. 5B). We cannot exclude the possibility of the effect of another factor or factors on NADPH generation or consumption in the zwf glcP mutant.
One of the most important findings of this study was that NTD/kanosamine had a significant impact on the central carbon metabolism of B. subtilis. The TCA cycle intermediate 2OG is a key metabolite that lies at the junction between the carbon and nitrogen metabolic pathways. This metabolite coordinates carbon and nitrogen metabolism in response to nutrient availability (24). Under nutrient-rich conditions, such as in our culture medium, which contained excess glucose and glutamate, only a small portion of pyruvate enters the TCA cycle (22, 23). Hence, the accumulated pyruvate feeds into overflow pathways that produce acetate and acetoin, both of which are excreted into the environment. Our metabolome data revealed that upregulation of the NTD/kanosamine biosynthetic pathway caused a significant increase in the 2OG pool (Fig. 4). The accumulation of 2OG was also observed in our preliminary metabolome analysis using the zwf+ glcP mutant (data not shown). It appears that NTD/kanosamine synthesis stimulated the later reactions of the TCA cycle (conversions from 2OG to malate) via the accumulation of 2OG. Considering that the expression of the acetoin biosynthesis operon alsSD was markedly reduced in the zwf+ glcP mutant (25), NTD/kanosamine biosynthesis might support a metabolic shift from glycolysis to gluconeogenesis by increasing the intracellular 2OG pool in stationary-phase cells. Although further analysis is needed to clarify the role of NTD/kanosamine in metabolism, NTD/kanosamine has the potential to play a role as a metabolic modulator in response to nutrient availability.
MATERIALS AND METHODS
Bacterial strains and chemicals.
All B. subtilis strains used in this study were derived from strain 168 and are listed in Table 1. Strain 1012 zwf gntZ (zwf::neo gntZ::spc) was kindly provided by Uwe Sauer (26). For the selection of B. subtilis transformants, neomycin (3 μg/ml), spectinomycin (100 μg/ml), chloramphenicol (4 μg/ml), and erythromycin (0.5 μg/ml) were used. NTD was previously prepared in our laboratory (10). Kanosamine hydrochloride was purchased from Santa Cruz Biotechnology, Inc. (USA). l-Malate monosodium salt was added to the growth medium at a final concentration of 0.2%. IPTG was used for the artificial expression of glcP.
TABLE 1.
Strains used in this study
| Strain | Genotype | Source or referencea |
|---|---|---|
| 168 | trpC2 | Laboratory stock |
| 1012 zwf gntZ | leuA8 metB5 zwf::neo gntZ::spc | 26 |
| TI122 | trpC2 aspB66 amyE::(PntdABC-lacZ cat) | 10 |
| TI127 | trpC2 aspB66 ntdR::neo amyE::(PntdABC-lacZ cat) | 10 |
| TI130 | trpC2 aspB66 ntdA::Tn10 amyE::(PntdABC-lacZ cat) | 14 |
| TI138 | trpC2 aspB66 ntdABC::cat | 14 |
| TI167 | trpC2 aspB66 ntdC-pMutinT3-TntdABC-glcP | 14 |
| TI168 | trpC2 aspB66 ntdC-TntdABC-pMutinT3-glcP | 14 |
| TI214 | trpC2 aspB66 glcP::spc | 25 |
| TI352 | trpC2 amyE::(PntdABC-lacZ cat) | TI122→168 |
| TI415 | trpC2 glcP::spc | TI214→168 |
| TI420 | trpC2 ntdC-TntdABC-pMutinT3-glcP | TI168→168 |
| TI422 | trpC2 ntdABC::cat glcP::spc | TI138→TI415 |
| TI443 | trpC2 zwf::neo | 1012 zwf gntZ→168 |
| TI444 | trpC2 zwf::neo glcP::spc | TI443→TI415 |
| TI445 | trpC2 zwf::neo ntdABC::cat glcP::spc | TI443→TI422 |
| TI451 | trpC2 zwf::neo ntdC-TntdABC-pMutinT3-glcP | TI443→TI420 |
| TI479 | trpC2 ntdC-pMutinT3-TntdABC-glcP | TI167→168 |
| TI480 | trpC2 zwf::neo ntdC-pMutinT3-TntdABC-glcP | TI443→TI479 |
| TI481 | trpC2 ntdR::neo amyE::(PntdABC-lacZ cat) | TI127→TI352 |
| TI482 | trpC2 ntdA::Tn10 amyE::(PntdABC-lacZ cat) | TI130→TI352 |
The arrows indicate construction by transformation of the latter strain with the genomic DNA of the former strain.
Growth conditions.
B. subtilis strains were maintained on 2× LB agar medium (20 g of tryptone, 10 g of yeast extract, 10 g of NaCl, and 15 g of agar per liter). Because the zwf mutants exhibited a dilution-sensitive growth, cells were never isolated as a single colony, with the exception of the selection of zwf transformants. To monitor growth in S7N medium (10 mM ammonium sulfate, 5 mM potassium phosphate [pH 7.0], 100 mM MOPS [morpholinepropanesulfonic acid; adjusted to pH 7.0 by KOH], 2 mM MgCl2, 0.7 mM CaCl2, 50 μM MnCl2, 5 μM FeCl3, 2 μM thiamine, 20 mM glutamate, 1% glucose, 50 μg/ml tryptophan, and 0.1% nutrient broth [Difco]), B. subtilis cells were inoculated in liquid LB medium (10 g of tryptone, 5 g of yeast extract, and 5 g of NaCl per liter) and cultivated for 16 h at 37°C with vigorous shaking. Subsequently, an appropriate volume of the culture was transferred into S7N medium and cultivated at 37°C with vigorous shaking.
β-Galactosidase assays.
β-Galactosidase activities were measured as described previously (27). The specific activities were calculated as (A420 × 1,000)/(min × ml of culture × OD650), where OD650 is the optical density at 650 nm.
Metabolome analysis.
A 16-h culture grown in LB medium was diluted 50-fold with S7N medium and cultivated at 37°C until the OD650 reached 0.2. Cells (10 absorbance units [ml of culture × OD650]) were collected by vacuum filtration using a filter with a pore size of 0.4 μm (Millipore) and quickly washed with 10 ml of Milli-Q water twice. The filter was immersed in 2 ml of methanol containing 2.5 μM (each) internal standards (methionine sulfone, morpholineethanesulfonic acid [MES], and d-camphor-10-sulfonic acid) for quantification. Cells were then removed from the filter in a bath sonication. A 1.6-ml portion of the cell suspension was mixed with an equal volume of chloroform and 640 μl of Milli-Q water. After vortexing and centrifugation, the aqueous layer was recovered and filtrated using Ultrafree-MC ultrafilter devices (Millipore) for metabolome analysis. After the filtrate was dried, the residue was dissolved in 25 μl of Milli-Q water containing 200 μM 3-aminopyrrolidine and trimesate as the internal standards for migration time correction. A metabolome analysis was conducted by capillary electrophoresis-time of flight mass spectrometry (CE-TOF MS). CE-TOF MS was carried out using an Agilent CE capillary electrophoresis system equipped with an Agilent 6210 time-of-flight mass spectrometer, an isocratic high-performance liquid chromatography (HPLC) pump, a CE-MS adapter kit, and a CE-electrospray ionization (ESI) MS sprayer kit (Agilent Technologies). The system was controlled by the Agilent Chem Station software for CE. The instrumental conditions used for analysis were as described previously (28).
NADPH assay.
One milliliter of LB overnight culture was inoculated into 100 ml of S7N medium and incubated at 37°C with vigorous shaking until the OD650 reached 0.2 to 0.3. The cells were then collected by centrifugation (6,000 rpm for 5 min at 25°C), washed with phosphate-buffered saline (PBS), and centrifuged again. After the supernatant was discarded, the cell pellet was kept at −20°C until use. The intracellular NADPH level was measured using an Amplite colorimetric NADPH assay kit (AAT Bioquest, USA), according to the manufacturer’s recommendations with slight modification. In brief, the cell pellet was resuspended in 0.5 ml of lysis buffer (component D in the kit; AAT Bioquest, USA) supplemented with 1 μl of DNase I (5 U/μl; TaKaRa, Japan) and incubated at room temperature for 30 min. After the cell debris was removed, the resulting crude extract was subjected to an NADPH assay. The NADPH level was normalized by adjusting the concentration of total protein. Protein concentrations were determined by using a bicinchoninic acid (BCA) protein assay kit (Pierce, USA).
Reverse transcription-quantitative PCR.
For reverse transcription-quantitative PCR (RT-qPCR), total cellular RNA was prepared as described previously (25). First-strand cDNA was synthesized using the PrimeScript RT reagent kit with gDNA Eraser (TaKaRa Bio, Japan) and random hexamer primers, according to the manufacturer’s instructions. Real-time PCR was performed using the Thunder Bird SYBR qPCR mix (Toyobo, Japan) on an ABI 7300 real-time PCR system (Applied Biosystems, USA). 16S rRNA was used for the normalization of RNA levels. The oligonucleotides used for the quantification of ntdA and 16S were described previously (25).
Supplementary Material
ACKNOWLEDGMENTS
We thank Uwe Sauer (ETH Zurich, Switzerland) for providing B. subtilis strain 1012 zwf gntZ (zwf::neo gntZ::spc).
This work was supported by JICA-Kirin fellowship program 2019-2020 (to H.M.N.) and the Japan Society for the Promotion of Science (JSPS) (17K15253 to T.I.).
Footnotes
Supplemental material is available online only.
REFERENCES
- 1.Camilli A, Bassler BL. 2006. Bacterial small-molecule signaling pathways. Science 311:1113–1116. 10.1126/science.1121357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rutherford ST, Bassler BL. 2012. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2:a012427. 10.1101/cshperspect.a012427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hense BA, Schuster M. 2015. Core principles of bacterial autoinducer systems. Microbiol Mol Biol Rev 79:153–169. 10.1128/MMBR.00024-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hawver LA, Jung SA, Ng W-L. 2016. Specificity and complexity in bacterial quorum-sensing systems. FEMS Microbiol Rev 40:738–752. 10.1093/femsre/fuw014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fuqua C, Parsek MR, Greenberg EP. 2001. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu Rev Genet 35:439–468. 10.1146/annurev.genet.35.102401.090913. [DOI] [PubMed] [Google Scholar]
- 6.Dunny GM, Leonard BA. 1997. Cell-cell communication in Gram-positive bacteria. Annu Rev Microbiol 51:527–564. 10.1146/annurev.micro.51.1.527. [DOI] [PubMed] [Google Scholar]
- 7.Xavier KB, Bassler BL. 2003. LuxS quorum sensing: more than just a numbers game. Curr Opin Microbiol 6:191–197. 10.1016/s1369-5274(03)00028-6. [DOI] [PubMed] [Google Scholar]
- 8.Numata K, Satoh F, Hatori M, Miyaki T, Kawaguchi H. 1986. Isolation of 3,3'-neotrehalosadiamine (BMY-28251) from a butirosin-producing organism. J Antibiot (Tokyo) 39:1346–1348. 10.7164/antibiotics.39.1346. [DOI] [PubMed] [Google Scholar]
- 9.Tsuno T, Ikeda C, Numata K, Tomita K, Konishi M, Kawaguchi H. 1986. 3,3'-Neotrehalosadiamine (BMY-28251), a new aminosugar antibiotic. J Antibiot (Tokyo) 39:1001–1003. 10.7164/antibiotics.39.1001. [DOI] [PubMed] [Google Scholar]
- 10.Inaoka T, Takahashi K, Yada H, Yoshida M, Ochi K. 2004. RNA polymerase mutation activates the production of a dormant antibiotic 3,3'-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis. J Biol Chem 279:3885–3892. 10.1074/jbc.M309925200. [DOI] [PubMed] [Google Scholar]
- 11.Vetter ND, Langill DM, Anjum S, Boisvert-Martel J, Jagdhane RC, Omene E, Zheng H, van Straaten KE, Asiamah I, Krol ES, Sanders DAR, Palmer DRJ. 2013. A previously unrecognized kanosamine biosynthesis pathway in Bacillus subtilis. J Am Chem Soc 135:5970–5973. 10.1021/ja4010255. [DOI] [PubMed] [Google Scholar]
- 12.van Straaten KE, Ko JB, Jagdhane R, Anjum S, Palmer DRJ, Sanders DAR. 2013. The structure of NtdA, a sugar aminotransferase involved in the kanosamine biosynthetic pathway in Bacillus subtilis, reveals a new subclass of aminotransferases. J Biol Chem 288:34121–34130. 10.1074/jbc.M113.500637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Paulsen IT, Chauvaux S, Choi P, Saier MHJR. 1998. Characterization of glucose-specific catabolite repression-resistant mutants of Bacillus subtilis: identification of a novel hexose: H+ symporter. J Bacteriol 180:498–504. 10.1128/JB.180.3.498-504.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Inaoka T, Ochi K. 2007. Glucose uptake pathway-specific regulation of synthesis of neotrehalosadiamine, a novel autoinducer produced in Bacillus subtilis. J Bacteriol 189:65–75. 10.1128/JB.01478-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Postma PW, Lengeler JW, Jacobson GR. 1993. Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria. Microbiol Rev 57:543–594. 10.1128/MR.57.3.543-594.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Deutscher J, Galinier A, Martin-Verstraete I. 2002. Carbohydrate uptake and metabolism. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and its closest relatives: from genes to cells. ASM Press, Washington, DC. [Google Scholar]
- 17.Lerondel G, Doan T, Zamboni N, Sauer U, Aymerich S. 2006. YtsJ has the major physiological role of the four paralogous malic enzyme isoforms in Bacillus subtilis. J Bacteriol 188:4727–4736. 10.1128/JB.00167-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kleijn RJ, Buescher JM, Chat LL, Jules M, Aymerich S, Sauer U. 2010. Metabolic fluxes during strong carbon catabolite repression by malate in Bacillus subtilis. J Biol Chem 285:1587–1596. 10.1074/jbc.M109.061747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tanaka K, Kobayashi K, Ogasawara N. 2003. The Bacillus subtilis YufLM two-component system regulates the expression of the malate transporters MaeN (YufR) and YflS, and is essential for utilization of malate in minimal medium. Microbiology (Reading) 149:2317–2329. 10.1099/mic.0.26257-0. [DOI] [PubMed] [Google Scholar]
- 20.Asai K, Baik SH, Kasahara Y, Moriya S, Ogasawara N. 2000. Regulation of the transport system for C4-dicarboxylic acids in Bacillus subtilis. Microbiology 146:263–271. 10.1099/00221287-146-2-263. [DOI] [PubMed] [Google Scholar]
- 21.Blencke H-M, Homuth G, Ludwig H, Mäder U, Hecker M, Stülke J. 2003. Transcriptional profiling of gene expression in response to glucose in Bacillus subtilis: regulation of the central metabolic pathways. Metab Eng 5:133–149. 10.1016/S1096-7176(03)00009-0. [DOI] [PubMed] [Google Scholar]
- 22.Kim HJ, Roux A, Sonenshein AL. 2002. Direct and indirect roles of CcpA in regulation of Bacillus subtilis Krebs cycle genes. Mol Microbiol 45:179–190. 10.1046/j.1365-2958.2002.03003.x. [DOI] [PubMed] [Google Scholar]
- 23.Molle V, Nakaura Y, Shivers RP, Yamaguchi H, Losick R, Fujita Y, Sonenshein AL. 2003. Additional targets of the Bacillus subtilis global regulator CodY identified by chromatin immunoprecipitation and genome-wide transcript analysis. J Bacteriol 185:1911–1922. 10.1128/jb.185.6.1911-1922.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Huergo LF, Dixon R. 2015. The emergence of 2-oxoglutarate as a master regulator metabolite. Microbiol Mol Biol Rev 79:419–435. 10.1128/MMBR.00038-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Inaoka T, Satomura T, Fujita Y, Ochi K. 2009. Novel gene regulation mediated by overproduction of secondary metabolite neotrehalosadiamine in Bacillus subtilis. FEMS Microbiol Lett 291:151–156. 10.1111/j.1574-6968.2008.01450.x. [DOI] [PubMed] [Google Scholar]
- 26.Zamboni N, Fischer E, Laudert D, Aymerich S, Hohmann H-P, Sauer U. 2004. The Bacillus subtilis yqjI gene encodes the NADP+-dependent 6-P-gluconate dehydrogenase in the pentose phosphate pathway. J Bacteriol 186:4528–4534. 10.1128/JB.186.14.4528-4534.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kim J-Y, Inaoka T, Hirooka K, Matsuoka H, Murata M, Ohki R, Adachi Y, Fujita Y, Ochi K. 2009. Identification and characterization of a novel multidrug resistance operon, mdtRP (yusOP), of Bacillus subtilis. J Bacteriol 191:3273–3281. 10.1128/JB.00151-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Saito N, Robert M, Kochi H, Matsuo G, Kakazu Y, Soga T, Tomita M. 2009. Metabolite profiling reveals YihU as a novel hydroxybutyrate dehydrogenase for alternative succinic semialdehyde metabolism in Escherichia coli. J Biol Chem 284:16442–16451. 10.1074/jbc.M109.002089. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


